Loading organizations...
§ Private Profile · New York City, NY, USA
Drug discovery company creating novel therapeutics from natural sources.
Lodo Therapeutics has raised $17.0M across 1 funding round.
Lodo Therapeutics has raised $17.0M in total across 1 funding round.
Lodo Therapeutics has raised $17.0M across 1 funding round. Most recently, it raised $17.0M Series A in January 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 11, 2016 | $17M Series A | — | AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Trevor Mundel, ELI Lilly And Company, Harris & Harris Group, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund For NEW York City, Watson Fund, WuXi AppTec | Announced |
Lodo Therapeutics has raised $17.0M in total across 1 funding round.
Lodo Therapeutics's investors include AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Trevor Mundel, Eli Lilly and Company, Harris & Harris Group, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, Watson Fund, WuXi AppTec.